Date of Presentation
5-2-2024 12:00 AM
College
Rowan-Virtua School of Osteopathic Medicine
Poster Abstract
This review examines the impact of dexmedetomidine, an alpha-2 adrenergic receptor agonist, on postoperative pain and opioid consumption in major abdominal surgery. Dexmedetomidine, known for its sedative, analgesic, and opioid-sparing properties, is increasingly used as an adjunct to anesthesia. Analyzing existing literature, the review found that dexmedetomidine administration alongside general anesthesia significantly improves postoperative pain management and reduces opioid consumption. Patients receiving dexmedetomidine reported decreased postoperative pain ratings and required fewer opioids during the recovery phase. Additionally, intraoperative dexmedetomidine use correlated with reduced postoperative pain severity and increased patient satisfaction compared to control groups. However, potential side effects such as bradycardia and hypotension were noted, necessitating careful patient selection and monitoring to mitigate risks. In conclusion, dexmedetomidine offers promising outcomes as an adjuvant for major abdominal surgery by providing effective analgesia while reducing reliance on opioids. Further research is warranted to optimize dosing and administration strategies, ensuring the safe and efficacious use of dexmedetomidine in perioperative care.
Keywords
Dexmedetomidine, anesthesia, anesthetics, abdominal surgery, Operative Surgical Procedure, postoperative pain, opioid consumption, Opioid Analgesics, patient safety, pain management
Disciplines
Anesthesia and Analgesia | Anesthesiology | Heterocyclic Compounds | Medicine and Health Sciences | Patient Safety | Surgery | Surgical Procedures, Operative
Document Type
Poster
DOI
10.31986/issn.2689-0690_rdw.stratford_research_day.1_2024
Included in
Anesthesia and Analgesia Commons, Anesthesiology Commons, Heterocyclic Compounds Commons, Patient Safety Commons, Surgery Commons, Surgical Procedures, Operative Commons
Effects of Dexmedetomidine as an Adjunct to General Anesthesia on Postoperative Pain and Opioid Consumption in Major Abdominal Surgery
This review examines the impact of dexmedetomidine, an alpha-2 adrenergic receptor agonist, on postoperative pain and opioid consumption in major abdominal surgery. Dexmedetomidine, known for its sedative, analgesic, and opioid-sparing properties, is increasingly used as an adjunct to anesthesia. Analyzing existing literature, the review found that dexmedetomidine administration alongside general anesthesia significantly improves postoperative pain management and reduces opioid consumption. Patients receiving dexmedetomidine reported decreased postoperative pain ratings and required fewer opioids during the recovery phase. Additionally, intraoperative dexmedetomidine use correlated with reduced postoperative pain severity and increased patient satisfaction compared to control groups. However, potential side effects such as bradycardia and hypotension were noted, necessitating careful patient selection and monitoring to mitigate risks. In conclusion, dexmedetomidine offers promising outcomes as an adjuvant for major abdominal surgery by providing effective analgesia while reducing reliance on opioids. Further research is warranted to optimize dosing and administration strategies, ensuring the safe and efficacious use of dexmedetomidine in perioperative care.